Profile of the Running ES Score & Positions of GeneSet Members on the Rank Ordered List
| Dataset | w6a_vs_wt_vs_wt.w6a_vs_wt.cls #ago1w6a_versus_ago1gfp.w6a_vs_wt.cls #ago1w6a_versus_ago1gfp_repos |
| Phenotype | w6a_vs_wt.cls#ago1w6a_versus_ago1gfp_repos |
| Upregulated in class | ago1w6a |
| GeneSet | HALLMARK_COMPLEMENT |
| Enrichment Score (ES) | 0.40389878 |
| Normalized Enrichment Score (NES) | 1.5618637 |
| Nominal p-value | 0.0025806453 |
| FDR q-value | 0.009229267 |
| FWER p-Value | 0.114 |
| PROBE | DESCRIPTION (from dataset) | GENE SYMBOL | GENE_TITLE | RANK IN GENE LIST | RANK METRIC SCORE | RUNNING ES | CORE ENRICHMENT | |
|---|---|---|---|---|---|---|---|---|
| 1 | C4BPB | NA | C4BPB Entrez, Source | complement component 4 binding protein, beta | 11 | 4.950 | 0.0216 | Yes |
| 2 | SERPINB2 | NA | SERPINB2 Entrez, Source | serpin peptidase inhibitor, clade B (ovalbumin), member 2 | 49 | 4.726 | 0.0407 | Yes |
| 3 | IL6 | NA | IL6 Entrez, Source | interleukin 6 (interferon, beta 2) | 148 | 4.301 | 0.0544 | Yes |
| 4 | DPP4 | NA | DPP4 Entrez, Source | dipeptidyl-peptidase 4 (CD26, adenosine deaminase complexing protein 2) | 213 | 4.083 | 0.0691 | Yes |
| 5 | C2 | NA | C2 Entrez, Source | complement component 2 | 271 | 3.833 | 0.0831 | Yes |
| 6 | CASP1 | NA | CASP1 Entrez, Source | caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase) | 302 | 3.732 | 0.0981 | Yes |
| 7 | ZFPM2 | NA | ZFPM2 Entrez, Source | zinc finger protein, multitype 2 | 368 | 3.524 | 0.1103 | Yes |
| 8 | CD55 | NA | CD55 Entrez, Source | CD55 molecule, decay accelerating factor for complement (Cromer blood group) | 431 | 3.362 | 0.1218 | Yes |
| 9 | CTSD | NA | CTSD Entrez, Source | cathepsin D (lysosomal aspartyl peptidase) | 476 | 3.265 | 0.1340 | Yes |
| 10 | CR2 | NA | CR2 Entrez, Source | complement component (3d/Epstein Barr virus) receptor 2 | 510 | 3.161 | 0.1463 | Yes |
| 11 | PLAT | NA | PLAT Entrez, Source | plasminogen activator, tissue | 516 | 3.147 | 0.1601 | Yes |
| 12 | CFH | NA | CFH Entrez, Source | complement factor H | 581 | 2.980 | 0.1699 | Yes |
| 13 | SERPINE1 | NA | SERPINE1 Entrez, Source | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 620 | 2.910 | 0.1808 | Yes |
| 14 | KYNU | NA | KYNU Entrez, Source | kynureninase (L-kynurenine hydrolase) | 675 | 2.781 | 0.1902 | Yes |
| 15 | PIK3CA | NA | PIK3CA Entrez, Source | phosphoinositide-3-kinase, catalytic, alpha polypeptide | 693 | 2.734 | 0.2015 | Yes |
| 16 | C1R | NA | C1R Entrez, Source | complement component 1, r subcomponent | 694 | 2.734 | 0.2137 | Yes |
| 17 | CA2 | NA | CA2 Entrez, Source | carbonic anhydrase II | 737 | 2.653 | 0.2233 | Yes |
| 18 | CTSB | NA | CTSB Entrez, Source | cathepsin B | 739 | 2.651 | 0.2351 | Yes |
| 19 | GNB4 | NA | GNB4 Entrez, Source | guanine nucleotide binding protein (G protein), beta polypeptide 4 | 778 | 2.592 | 0.2446 | Yes |
| 20 | ADAM9 | NA | ADAM9 Entrez, Source | ADAM metallopeptidase domain 9 (meltrin gamma) | 840 | 2.488 | 0.2523 | Yes |
| 21 | F3 | NA | F3 Entrez, Source | coagulation factor III (thromboplastin, tissue factor) | 876 | 2.438 | 0.2612 | Yes |
| 22 | L3MBTL4 | NA | L3MBTL4 Entrez, Source | l(3)mbt-like 4 (Drosophila) | 902 | 2.407 | 0.2706 | Yes |
| 23 | SERPING1 | NA | SERPING1 Entrez, Source | serpin peptidase inhibitor, clade G (C1 inhibitor), member 1, (angioedema, hereditary) | 993 | 2.294 | 0.2758 | Yes |
| 24 | LRP1 | NA | LRP1 Entrez, Source | low density lipoprotein-related protein 1 (alpha-2-macroglobulin receptor) | 1013 | 2.276 | 0.2850 | Yes |
| 25 | PPP2CB | NA | PPP2CB Entrez, Source | protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform | 1016 | 2.274 | 0.2951 | Yes |
| 26 | IRF7 | NA | IRF7 Entrez, Source | interferon regulatory factor 7 | 1058 | 2.215 | 0.3027 | Yes |
| 27 | CASP9 | NA | CASP9 Entrez, Source | caspase 9, apoptosis-related cysteine peptidase | 1081 | 2.192 | 0.3113 | Yes |
| 28 | PHEX | NA | PHEX Entrez, Source | phosphate regulating endopeptidase homolog, X-linked (hypophosphatemia, vitamin D resistant rickets) | 1091 | 2.180 | 0.3205 | Yes |
| 29 | CFB | NA | CFB Entrez, Source | complement factor B | 1197 | 2.041 | 0.3238 | Yes |
| 30 | MMP14 | NA | MMP14 Entrez, Source | matrix metallopeptidase 14 (membrane-inserted) | 1202 | 2.038 | 0.3327 | Yes |
| 31 | CASP10 | NA | CASP10 Entrez, Source | caspase 10, apoptosis-related cysteine peptidase | 1339 | 1.895 | 0.3335 | Yes |
| 32 | CPM | NA | CPM Entrez, Source | carboxypeptidase M | 1404 | 1.841 | 0.3382 | Yes |
| 33 | TIMP2 | NA | TIMP2 Entrez, Source | TIMP metallopeptidase inhibitor 2 | 1421 | 1.826 | 0.3454 | Yes |
| 34 | TMPRSS6 | NA | TMPRSS6 Entrez, Source | transmembrane protease, serine 6 | 1425 | 1.823 | 0.3534 | Yes |
| 35 | HSPA1A | NA | HSPA1A Entrez, Source | heat shock 70kDa protein 1A | 1614 | 1.675 | 0.3504 | Yes |
| 36 | CDA | NA | CDA Entrez, Source | cytidine deaminase | 1705 | 1.598 | 0.3525 | Yes |
| 37 | GPD2 | NA | GPD2 Entrez, Source | glycerol-3-phosphate dehydrogenase 2 (mitochondrial) | 1830 | 1.511 | 0.3523 | Yes |
| 38 | PLG | NA | PLG Entrez, Source | plasminogen | 1857 | 1.494 | 0.3575 | Yes |
| 39 | ERAP2 | NA | 1889 | 1.477 | 0.3624 | Yes | ||
| 40 | PRCP | NA | PRCP Entrez, Source | prolylcarboxypeptidase (angiotensinase C) | 2002 | 1.420 | 0.3625 | Yes |
| 41 | LTF | NA | LTF Entrez, Source | lactotransferrin | 2027 | 1.409 | 0.3674 | Yes |
| 42 | TFPI2 | NA | TFPI2 Entrez, Source | tissue factor pathway inhibitor 2 | 2068 | 1.382 | 0.3714 | Yes |
| 43 | BRPF3 | NA | BRPF3 Entrez, Source | bromodomain and PHD finger containing, 3 | 2259 | 1.276 | 0.3664 | Yes |
| 44 | CDK5R1 | NA | CDK5R1 Entrez, Source | cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 2285 | 1.262 | 0.3706 | Yes |
| 45 | RABIF | NA | RABIF Entrez, Source | RAB interacting factor | 2331 | 1.242 | 0.3737 | Yes |
| 46 | PIM1 | NA | PIM1 Entrez, Source | pim-1 oncogene | 2367 | 1.227 | 0.3772 | Yes |
| 47 | CR1 | NA | CR1 Entrez, Source | complement component (3b/4b) receptor 1 (Knops blood group) | 2414 | 1.210 | 0.3801 | Yes |
| 48 | CEBPB | NA | CEBPB Entrez, Source | CCAAT/enhancer binding protein (C/EBP), beta | 2422 | 1.206 | 0.3851 | Yes |
| 49 | PSEN1 | NA | PSEN1 Entrez, Source | presenilin 1 (Alzheimer disease 3) | 2426 | 1.203 | 0.3903 | Yes |
| 50 | IRF1 | NA | IRF1 Entrez, Source | interferon regulatory factor 1 | 2439 | 1.197 | 0.3950 | Yes |
| 51 | HSPA5 | NA | HSPA5 Entrez, Source | heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 2543 | 1.161 | 0.3944 | Yes |
| 52 | CBLB | NA | CBLB Entrez, Source | Cas-Br-M (murine) ecotropic retroviral transforming sequence b | 2690 | 1.101 | 0.3911 | Yes |
| 53 | DUSP6 | NA | DUSP6 Entrez, Source | dual specificity phosphatase 6 | 2722 | 1.091 | 0.3942 | Yes |
| 54 | KCNIP3 | NA | KCNIP3 Entrez, Source | Kv channel interacting protein 3, calsenilin | 2746 | 1.081 | 0.3978 | Yes |
| 55 | CP | NA | CP Entrez, Source | ceruloplasmin (ferroxidase) | 2849 | 1.044 | 0.3967 | Yes |
| 56 | STX4 | NA | STX4 Entrez, Source | syntaxin 4 | 2871 | 1.039 | 0.4002 | Yes |
| 57 | LGMN | NA | LGMN Entrez, Source | legumain | 2948 | 1.006 | 0.4005 | Yes |
| 58 | RASGRP1 | NA | RASGRP1 Entrez, Source | RAS guanyl releasing protein 1 (calcium and DAG-regulated) | 3019 | 0.986 | 0.4009 | Yes |
| 59 | MMP15 | NA | MMP15 Entrez, Source | matrix metallopeptidase 15 (membrane-inserted) | 3045 | 0.975 | 0.4039 | Yes |
| 60 | TIMP1 | NA | TIMP1 Entrez, Source | TIMP metallopeptidase inhibitor 1 | 3284 | 0.917 | 0.3946 | No |
| 61 | C1S | NA | C1S Entrez, Source | complement component 1, s subcomponent | 3847 | 0.800 | 0.3666 | No |
| 62 | DOCK10 | NA | DOCK10 Entrez, Source | dedicator of cytokinesis 10 | 3868 | 0.795 | 0.3691 | No |
| 63 | ANXA5 | NA | ANXA5 Entrez, Source | annexin A5 | 3903 | 0.784 | 0.3707 | No |
| 64 | RNF4 | NA | RNF4 Entrez, Source | ring finger protein 4 | 4239 | 0.713 | 0.3550 | No |
| 65 | JAK2 | NA | JAK2 Entrez, Source | Janus kinase 2 (a protein tyrosine kinase) | 4325 | 0.696 | 0.3534 | No |
| 66 | WAS | NA | WAS Entrez, Source | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 4347 | 0.690 | 0.3553 | No |
| 67 | EHD1 | NA | EHD1 Entrez, Source | EH-domain containing 1 | 4513 | 0.654 | 0.3489 | No |
| 68 | PCLO | NA | PCLO Entrez, Source | piccolo (presynaptic cytomatrix protein) | 4602 | 0.638 | 0.3468 | No |
| 69 | CCL5 | NA | CCL5 Entrez, Source | chemokine (C-C motif) ligand 5 | 4674 | 0.624 | 0.3456 | No |
| 70 | APOBEC3G | NA | APOBEC3G Entrez, Source | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G | 4699 | 0.616 | 0.3471 | No |
| 71 | LAP3 | NA | LAP3 Entrez, Source | leucine aminopeptidase 3 | 4752 | 0.606 | 0.3468 | No |
| 72 | LGALS3 | NA | LGALS3 Entrez, Source | lectin, galactoside-binding, soluble, 3 (galectin 3) | 4778 | 0.599 | 0.3481 | No |
| 73 | F5 | NA | F5 Entrez, Source | coagulation factor V (proaccelerin, labile factor) | 5126 | 0.531 | 0.3310 | No |
| 74 | PRDM4 | NA | PRDM4 Entrez, Source | PR domain containing 4 | 5174 | 0.523 | 0.3307 | No |
| 75 | CTSO | NA | CTSO Entrez, Source | cathepsin O | 5245 | 0.510 | 0.3290 | No |
| 76 | CD46 | NA | CD46 Entrez, Source | CD46 molecule, complement regulatory protein | 5468 | 0.483 | 0.3187 | No |
| 77 | LCP2 | NA | LCP2 Entrez, Source | lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa) | 5582 | 0.463 | 0.3144 | No |
| 78 | RCE1 | NA | RCE1 Entrez, Source | RCE1 homolog, prenyl protein peptidase (S. cerevisiae) | 5705 | 0.443 | 0.3096 | No |
| 79 | GP1BA | NA | GP1BA Entrez, Source | glycoprotein Ib (platelet), alpha polypeptide | 5717 | 0.441 | 0.3109 | No |
| 80 | S100A12 | NA | S100A12 Entrez, Source | S100 calcium binding protein A12 | 5977 | 0.418 | 0.2982 | No |
| 81 | FCN1 | NA | FCN1 Entrez, Source | ficolin (collagen/fibrinogen domain containing) 1 | 6030 | 0.418 | 0.2972 | No |
| 82 | HNF4A | NA | HNF4A Entrez, Source | hepatocyte nuclear factor 4, alpha | 6236 | 0.409 | 0.2875 | No |
| 83 | PCSK9 | NA | PCSK9 Entrez, Source | proprotein convertase subtilisin/kexin type 9 | 6261 | 0.405 | 0.2880 | No |
| 84 | FYN | NA | FYN Entrez, Source | FYN oncogene related to SRC, FGR, YES | 6328 | 0.393 | 0.2860 | No |
| 85 | GATA3 | NA | GATA3 Entrez, Source | GATA binding protein 3 | 6358 | 0.389 | 0.2861 | No |
| 86 | GP9 | NA | GP9 Entrez, Source | glycoprotein IX (platelet) | 6609 | 0.349 | 0.2736 | No |
| 87 | USP14 | NA | USP14 Entrez, Source | ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) | 6642 | 0.343 | 0.2734 | No |
| 88 | SIRT6 | NA | SIRT6 Entrez, Source | sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae) | 6769 | 0.325 | 0.2677 | No |
| 89 | ATOX1 | NA | ATOX1 Entrez, Source | ATX1 antioxidant protein 1 homolog (yeast) | 6937 | 0.300 | 0.2597 | No |
| 90 | RHOG | NA | RHOG Entrez, Source | ras homolog gene family, member G (rho G) | 6947 | 0.298 | 0.2605 | No |
| 91 | CASP7 | NA | CASP7 Entrez, Source | caspase 7, apoptosis-related cysteine peptidase | 7071 | 0.278 | 0.2549 | No |
| 92 | USP15 | NA | USP15 Entrez, Source | ubiquitin specific peptidase 15 | 7234 | 0.253 | 0.2469 | No |
| 93 | CALM1 | NA | CALM1 Entrez, Source | calmodulin 1 (phosphorylase kinase, delta) | 7356 | 0.233 | 0.2411 | No |
| 94 | CASP5 | NA | CASP5 Entrez, Source | caspase 5, apoptosis-related cysteine peptidase | 7383 | 0.229 | 0.2407 | No |
| 95 | LAMP2 | NA | LAMP2 Entrez, Source | lysosomal-associated membrane protein 2 | 7616 | 0.196 | 0.2285 | No |
| 96 | PLAUR | NA | PLAUR Entrez, Source | plasminogen activator, urokinase receptor | 7676 | 0.188 | 0.2261 | No |
| 97 | MMP13 | NA | MMP13 Entrez, Source | matrix metallopeptidase 13 (collagenase 3) | 7677 | 0.188 | 0.2269 | No |
| 98 | SH2B3 | NA | SH2B3 Entrez, Source | SH2B adaptor protein 3 | 7866 | 0.164 | 0.2171 | No |
| 99 | SCG3 | NA | SCG3 Entrez, Source | secretogranin III | 7892 | 0.159 | 0.2164 | No |
| 100 | PLA2G7 | NA | PLA2G7 Entrez, Source | phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma) | 7920 | 0.155 | 0.2155 | No |
| 101 | FDX1 | NA | FDX1 Entrez, Source | ferredoxin 1 | 8135 | 0.128 | 0.2041 | No |
| 102 | C9 | NA | C9 Entrez, Source | complement component 9 | 8168 | 0.125 | 0.2028 | No |
| 103 | ADRA2B | NA | ADRA2B Entrez, Source | adrenergic, alpha-2B-, receptor | 8270 | 0.111 | 0.1977 | No |
| 104 | CSRP1 | NA | CSRP1 Entrez, Source | cysteine and glycine-rich protein 1 | 8408 | 0.092 | 0.1904 | No |
| 105 | CTSC | NA | CTSC Entrez, Source | cathepsin C | 8707 | 0.051 | 0.1739 | No |
| 106 | VCPIP1 | NA | VCPIP1 Entrez, Source | valosin containing protein (p97)/p47 complex interacting protein 1 | 9080 | 0.009 | 0.1530 | No |
| 107 | LIPA | NA | LIPA Entrez, Source | lipase A, lysosomal acid, cholesterol esterase (Wolman disease) | 9120 | 0.008 | 0.1508 | No |
| 108 | APOA4 | NA | APOA4 Entrez, Source | apolipoprotein A-IV | 9191 | 0.000 | 0.1469 | No |
| 109 | GZMK | NA | GZMK Entrez, Source | granzyme K (granzyme 3; tryptase II) | 9234 | 0.000 | 0.1445 | No |
| 110 | CD36 | NA | CD36 Entrez, Source | CD36 molecule (thrombospondin receptor) | 9407 | -0.000 | 0.1349 | No |
| 111 | CD59 | NA | CD59 Entrez, Source | CD59 molecule, complement regulatory protein | 9435 | -0.005 | 0.1334 | No |
| 112 | F10 | NA | F10 Entrez, Source | coagulation factor X | 9456 | -0.007 | 0.1323 | No |
| 113 | MMP8 | NA | MMP8 Entrez, Source | matrix metallopeptidase 8 (neutrophil collagenase) | 9576 | -0.026 | 0.1257 | No |
| 114 | APOBEC3F | NA | APOBEC3F Entrez, Source | apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F | 9658 | -0.038 | 0.1213 | No |
| 115 | DUSP5 | NA | DUSP5 Entrez, Source | dual specificity phosphatase 5 | 9791 | -0.051 | 0.1141 | No |
| 116 | GZMA | NA | GZMA Entrez, Source | granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) | 9874 | -0.062 | 0.1098 | No |
| 117 | ME1 | NA | ME1 Entrez, Source | malic enzyme 1, NADP(+)-dependent, cytosolic | 10031 | -0.072 | 0.1013 | No |
| 118 | LYN | NA | LYN Entrez, Source | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 10237 | -0.091 | 0.0902 | No |
| 119 | F7 | NA | F7 Entrez, Source | coagulation factor VII (serum prothrombin conversion accelerator) | 10325 | -0.099 | 0.0858 | No |
| 120 | KCNIP2 | NA | KCNIP2 Entrez, Source | Kv channel interacting protein 2 | 10423 | -0.113 | 0.0808 | No |
| 121 | GNB2 | NA | GNB2 Entrez, Source | guanine nucleotide binding protein (G protein), beta polypeptide 2 | 10498 | -0.124 | 0.0772 | No |
| 122 | SRC | NA | SRC Entrez, Source | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 10694 | -0.154 | 0.0669 | No |
| 123 | LTA4H | NA | LTA4H Entrez, Source | leukotriene A4 hydrolase | 10705 | -0.155 | 0.0671 | No |
| 124 | GNAI3 | NA | GNAI3 Entrez, Source | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3 | 10843 | -0.176 | 0.0602 | No |
| 125 | DGKG | NA | DGKG Entrez, Source | diacylglycerol kinase, gamma 90kDa | 10937 | -0.189 | 0.0558 | No |
| 126 | MMP12 | NA | MMP12 Entrez, Source | matrix metallopeptidase 12 (macrophage elastase) | 11095 | -0.211 | 0.0479 | No |
| 127 | KLKB1 | NA | KLKB1 Entrez, Source | kallikrein B, plasma (Fletcher factor) 1 | 11119 | -0.214 | 0.0476 | No |
| 128 | PRSS36 | NA | PRSS36 Entrez, Source | protease, serine, 36 | 11183 | -0.225 | 0.0450 | No |
| 129 | PIK3R5 | NA | PIK3R5 Entrez, Source | phosphoinositide-3-kinase, regulatory subunit 5, p101 | 11218 | -0.228 | 0.0441 | No |
| 130 | PLEK | NA | PLEK Entrez, Source | pleckstrin | 11478 | -0.268 | 0.0308 | No |
| 131 | AKAP10 | NA | AKAP10 Entrez, Source | A kinase (PRKA) anchor protein 10 | 11613 | -0.285 | 0.0245 | No |
| 132 | ANG | NA | ANG Entrez, Source | angiogenin, ribonuclease, RNase A family, 5 | 11634 | -0.288 | 0.0247 | No |
| 133 | KLK1 | NA | KLK1 Entrez, Source | kallikrein 1, renal/pancreas/salivary | 11895 | -0.327 | 0.0115 | No |
| 134 | PPP4C | NA | PPP4C Entrez, Source | protein phosphatase 4 (formerly X), catalytic subunit | 11964 | -0.334 | 0.0092 | No |
| 135 | GRB2 | NA | GRB2 Entrez, Source | growth factor receptor-bound protein 2 | 12041 | -0.344 | 0.0065 | No |
| 136 | OLR1 | NA | OLR1 Entrez, Source | oxidised low density lipoprotein (lectin-like) receptor 1 | 12060 | -0.347 | 0.0070 | No |
| 137 | PSMB9 | NA | PSMB9 Entrez, Source | proteasome (prosome, macropain) subunit, beta type, 9 (large multifunctional peptidase 2) | 12068 | -0.349 | 0.0082 | No |
| 138 | PDP1 | NA | 12121 | -0.357 | 0.0069 | No | ||
| 139 | DOCK9 | NA | DOCK9 Entrez, Source | dedicator of cytokinesis 9 | 12274 | -0.379 | 0.0000 | No |
| 140 | CD40LG | NA | CD40LG Entrez, Source | CD40 ligand (TNF superfamily, member 5, hyper-IgM syndrome) | 12489 | -0.411 | -0.0102 | No |
| 141 | FN1 | NA | FN1 Entrez, Source | fibronectin 1 | 12699 | -0.434 | -0.0200 | No |
| 142 | RAF1 | NA | RAF1 Entrez, Source | v-raf-1 murine leukemia viral oncogene homolog 1 | 12700 | -0.434 | -0.0180 | No |
| 143 | IRF2 | NA | IRF2 Entrez, Source | interferon regulatory factor 2 | 12738 | -0.441 | -0.0181 | No |
| 144 | CALM3 | NA | CALM3 Entrez, Source | calmodulin 3 (phosphorylase kinase, delta) | 12891 | -0.450 | -0.0247 | No |
| 145 | S100A13 | NA | S100A13 Entrez, Source | S100 calcium binding protein A13 | 12976 | -0.452 | -0.0274 | No |
| 146 | MAFF | NA | MAFF Entrez, Source | v-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian) | 13007 | -0.456 | -0.0270 | No |
| 147 | F8 | NA | F8 Entrez, Source | coagulation factor VIII, procoagulant component (hemophilia A) | 13126 | -0.477 | -0.0315 | No |
| 148 | HPCAL4 | NA | HPCAL4 Entrez, Source | hippocalcin like 4 | 13206 | -0.490 | -0.0337 | No |
| 149 | SPOCK2 | NA | SPOCK2 Entrez, Source | sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2 | 13299 | -0.503 | -0.0367 | No |
| 150 | GMFB | NA | GMFB Entrez, Source | glia maturation factor, beta | 13373 | -0.514 | -0.0385 | No |
| 151 | DYRK2 | NA | DYRK2 Entrez, Source | dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2 | 13472 | -0.530 | -0.0416 | No |
| 152 | KIF2A | NA | KIF2A Entrez, Source | kinesin heavy chain member 2A | 13493 | -0.534 | -0.0403 | No |
| 153 | SERPINC1 | NA | SERPINC1 Entrez, Source | serpin peptidase inhibitor, clade C (antithrombin), member 1 | 13702 | -0.576 | -0.0494 | No |
| 154 | CASP4 | NA | CASP4 Entrez, Source | caspase 4, apoptosis-related cysteine peptidase | 14105 | -0.660 | -0.0691 | No |
| 155 | PFN1 | NA | PFN1 Entrez, Source | profilin 1 | 14577 | -0.772 | -0.0921 | No |
| 156 | USP16 | NA | USP16 Entrez, Source | ubiquitin specific peptidase 16 | 14674 | -0.794 | -0.0939 | No |
| 157 | GNAI2 | NA | GNAI2 Entrez, Source | guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2 | 14733 | -0.810 | -0.0936 | No |
| 158 | PLA2G4A | NA | PLA2G4A Entrez, Source | phospholipase A2, group IVA (cytosolic, calcium-dependent) | 14893 | -0.842 | -0.0987 | No |
| 159 | PRSS3 | NA | PRSS3 Entrez, Source | protease, serine, 3 (mesotrypsin) | 15281 | -0.936 | -0.1163 | No |
| 160 | PLSCR1 | NA | PLSCR1 Entrez, Source | phospholipid scramblase 1 | 15338 | -0.951 | -0.1152 | No |
| 161 | ITIH1 | NA | ITIH1 Entrez, Source | inter-alpha (globulin) inhibitor H1 | 15404 | -0.969 | -0.1145 | No |
| 162 | ACTN2 | NA | ACTN2 Entrez, Source | actinin, alpha 2 | 15457 | -0.986 | -0.1130 | No |
| 163 | DGKH | NA | DGKH Entrez, Source | diacylglycerol kinase, eta | 15701 | -1.062 | -0.1219 | No |
| 164 | CTSH | NA | CTSH Entrez, Source | cathepsin H | 15762 | -1.081 | -0.1204 | No |
| 165 | LCK | NA | LCK Entrez, Source | lymphocyte-specific protein tyrosine kinase | 15773 | -1.086 | -0.1161 | No |
| 166 | ZEB1 | NA | 15785 | -1.089 | -0.1119 | No | ||
| 167 | GCA | NA | GCA Entrez, Source | grancalcin, EF-hand calcium binding protein | 15895 | -1.134 | -0.1129 | No |
| 168 | FCER1G | NA | FCER1G Entrez, Source | Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide | 16114 | -1.221 | -0.1197 | No |
| 169 | APOC1 | NA | APOC1 Entrez, Source | apolipoprotein C-I | 16377 | -1.349 | -0.1284 | No |
| 170 | XPNPEP1 | NA | XPNPEP1 Entrez, Source | X-prolyl aminopeptidase (aminopeptidase P) 1, soluble | 16394 | -1.360 | -0.1232 | No |
| 171 | PREP | NA | PREP Entrez, Source | prolyl endopeptidase | 16469 | -1.399 | -0.1211 | No |
| 172 | TNFAIP3 | NA | TNFAIP3 Entrez, Source | tumor necrosis factor, alpha-induced protein 3 | 16490 | -1.410 | -0.1159 | No |
| 173 | CXCL1 | NA | CXCL1 Entrez, Source | chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha) | 16731 | -1.552 | -0.1224 | No |
| 174 | COL4A2 | NA | COL4A2 Entrez, Source | collagen, type IV, alpha 2 | 16767 | -1.575 | -0.1174 | No |
| 175 | SERPINA1 | NA | SERPINA1 Entrez, Source | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 | 16974 | -1.746 | -0.1211 | No |
| 176 | DOCK4 | NA | DOCK4 Entrez, Source | dedicator of cytokinesis 4 | 17099 | -1.875 | -0.1197 | No |
| 177 | F2 | NA | F2 Entrez, Source | coagulation factor II (thrombin) | 17157 | -1.953 | -0.1141 | No |
| 178 | CASP3 | NA | CASP3 Entrez, Source | caspase 3, apoptosis-related cysteine peptidase | 17177 | -1.978 | -0.1063 | No |
| 179 | ITGAM | NA | ITGAM Entrez, Source | integrin, alpha M (complement component 3 receptor 3 subunit) | 17198 | -2.003 | -0.0985 | No |
| 180 | PRKCD | NA | PRKCD Entrez, Source | protein kinase C, delta | 17443 | -2.401 | -0.1014 | No |
| 181 | CDH13 | NA | CDH13 Entrez, Source | cadherin 13, H-cadherin (heart) | 17527 | -2.555 | -0.0947 | No |
| 182 | C3 | NA | C3 Entrez, Source | complement component 3 | 17698 | -3.089 | -0.0904 | No |
| 183 | PDGFB | NA | PDGFB Entrez, Source | platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog) | 17712 | -3.137 | -0.0771 | No |
| 184 | CTSS | NA | CTSS Entrez, Source | cathepsin S | 17772 | -3.468 | -0.0648 | No |
| 185 | GNG2 | NA | GNG2 Entrez, Source | guanine nucleotide binding protein (G protein), gamma 2 | 17843 | -3.833 | -0.0516 | No |
| 186 | NOTCH4 | NA | NOTCH4 Entrez, Source | Notch homolog 4 (Drosophila) | 17862 | -4.034 | -0.0345 | No |
| 187 | PIK3CG | NA | PIK3CG Entrez, Source | phosphoinositide-3-kinase, catalytic, gamma polypeptide | 17882 | -4.130 | -0.0171 | No |
| 188 | GNGT2 | NA | GNGT2 Entrez, Source | guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2 | 17967 | -4.954 | 0.0004 | No |
